GlassScriptPhysician profile
Jennifer P Peele
NPI 1619318870
$3,036.90
in general payments reported to CMS, 2019-2025
37 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 87% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $372 · 2023: $401 · 2024: $544 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813 · Education: $267 · Travel and Lodging: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.52 |
| Education | $266.98 |
| Travel and Lodging | $263.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $549.24 | 2025 | Neurostar Tms Therapy System |
| Jazz Pharmaceuticals INC. | $400.03 | 2021-2025 | |
| Harmony Biosciences LLC | $354.42 | 2022-2025 | Wakix |
| Tris Pharma INC | $177.52 | 2024-2025 | Dyanavel Xr, Quillivant, Quillichew Er |
| Inspire Medical Systems, INC. | $166.98 | 2023 | Inspire |
| Supernus Pharmaceuticals, INC. | $141.72 | 2024-2025 | Qelbree |
| Janssen Pharmaceuticals, INC | $137.74 | 2023-2025 | Spravato, Xarelto |
| E.R. Squibb & Sons, L.L.C. | $120.96 | 2025 | Cobenfy |
| Abbott Laboratories | $101.56 | 2022-2024 | Freestyle Libre 3 |
| Vanda Pharmaceuticals INC. | $88.75 | 2021-2025 | Hetlioz, Fanapt |
| Eisai INC. | $69.74 | 2021 | |
| Tempus Ai, INC | $67.36 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $64.49 | 2025 | Caplyta |
| Lundbeck LLC | $58.80 | 2025 | Rexulti |
| Axsome Therapeutics, INC. | $52.05 | 2024-2025 | Auvelity |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.63 | 2022 | |
| Baxter Healthcare | $42.54 | 2022 | |
| Collegium Pharmaceutical, INC. | $41.85 | 2025 | Jornay Pm |
| Regeneron Healthcare Solutions, INC. | $39.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $32.94 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.74 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $25.50 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $20.46 | 2025 | Rexulti |
| Arbor Pharmaceuticals, INC. | $19.83 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.11 | 2025 | Trintellix |
| Impulse Dynamics (USA) INC. | $18.99 | 2023 | Optimizer |
| Abbvie INC. | $18.58 | 2024 | |
| United Therapeutics Corporation | $16.58 | 2022 | |
| Novo Nordisk INC | $15.19 | 2024 | Wegovy |
| Philips North America LLC | $14.96 | 2022 | |
| Neurocrine Biosciences, INC. | $14.68 | 2024 | Ingrezza |
| Inogen, INC. | $14.10 | 2021 | |
| Glaxosmithkline, LLC. | $13.86 | 2022 | |
| Sandoz INC. | $12.24 | 2022 | |
| Resmed Corp | $12.01 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.24 | 2021 | |
| Genzyme Corporation | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Peele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.